Baseline demographics of subjects
| Characteristic | Misoprostol 400 µg (n=40) | Misoprostol 200 µg (n=37) | Gemeprost 1 mg (n=39) |
| Age (years) | 25.4 (4.7) | 27.0 (4.7) | 27.6 (5.5) |
| BMI (kg/m2) | 22.8 (4.5) | 23.5 (4.2) | 23.7 (4.4) |
| Gestational age (weeks) | 16.8 (2.9) | 16.8 (4.2) | 18.4 (3.2) |
| Nulliparous | 24 (60.0%) | 16 (43.2%) | 20 (51.3%) |
| Primigravida | 14 (35.0%) | 10 (27.0%) | 12 (30.8%) |
| First TOP | 29 (72.5%) | 18 (48.6%) | 21 (53.8%) |
| Indication | |||
| Unwanted pregnancies | 32 (80.0%) | 33 (89.2%) | 32 (82.1%) |
| Fetal anomaly | 8 (20.0%) | 4 (10.8%) | 7 (17.9%) |
Values are expressed as mean (± standard deviation) for continuous variables or number (percentage) for categorical variables.
BMI, body mass index; TOP, termination of pregnancy.